The minimal impact of food on the pharmacokinetics of ridaforolimus
Cancer Chemotherapy and Pharmacology, 06/15/2012
Stroh M et al. – Increases in ridaforolimus exposure following both the light and high–fat breakfasts were not considered to be clinically meaningful. Ridaforolimus was generally well tolerated, and there were no discontinuations due to drug–related AEs. Ridaforolimus should be given without regard to food.